Thomas DiRaimondo

Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.

Net worth: 2 M $ as of 30/07/2026

40 year

Consumer Services

Health Technology

Profile

Thomas DiRaimondo is the founder of Sitari Pharma, Inc., founded in 2013.
Dr. DiRaimondo currently holds the position of Chief Scientific Officer at Janux Therapeutics, Inc., starting in 2024.
Education history includes a doctorate from Stanford University and undergraduate and graduate degrees from the University of Michigan.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
JANUX THERAPEUTICS, INC. 0.18%	14/02/2026	106,425 ( 0.18% )	2 M $	30/07/2026

Thomas DiRaimondo active positions

Companies	Position	Start
JANUX THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	30/04/2018

All active positions of Thomas DiRaimondo

Former positions of Thomas DiRaimondo

Companies	Position	End
Sitari Pharma, Inc. Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services	Founder	31/07/2019

See the detail of Thomas DiRaimondo's experience

Training of Thomas DiRaimondo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas DiRaimondo's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sitari Pharma, Inc. Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services	Health Technology
Janux Therapeutics, Inc. Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies	Health Technology